Dr. Anna Arakelyan, MD

Dr. Arakelyan practices at Adventist Health Glendale in Glendale, California, part of Adventist Health.

Dr. Arakelyan's NPI, 1326508029, was assigned on March 20, 2019. Dr. Arakelyan graduated from Ross University School of Medicine in 2018. Dr. Arakelyan holds California license A176385.

Dr. Arakelyan's primary practice is Adventist Health Glendale, at 1509 E Wilson Terrace, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 409-8202.

Dr. Arakelyan's primary practice is Adventist Health Glendale in Glendale, California, part of Adventist Health. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Arakelyan to 4 more group practices and clinics, 3 hospices and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arakelyan practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Arakelyan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Arakelyan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Arakelyan is licensed in California.

Dmand AI lists acute gastroduodenitis, acute sinusitis, arthritis, atrial fibrillation and flutter, bile duct problems, bronchitis, cardiac arrhythmia and chronic anemia among the conditions Dr. Arakelyan treats.

CMS data shows 257 Medicare services from Dr. Arakelyan across 5 procedure codes in 2024, for 71 Medicare patients. Medicare paid $14,579 for them. Every service was in an office.

CMS counts 71 Medicare patients who saw Dr. Arakelyan in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arakelyan's median patient age at 60, with 64% women.

In 2024, Dr. Arakelyan wrote 2,295 Medicare Part D claims for 195 patients. 81% of them were for generic drugs. CMS names the drug for 1,749 of them, across 55 drugs with 11 or more claims each, at $237,895 in total drug cost. In 2023, CMS named 1,256 claims across 48 drugs.

Dr. Arakelyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arakelyan as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 17 general payments to Dr. Arakelyan from 8 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $286.

Dr. Arakelyan graduated from Ross University School of Medicine in 2018.

Dr. Arakelyan is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.